Jupiter Topco LLC Takes Position in Addus HomeCare Corporation $ADUS

Jupiter Topco LLC purchased a new position in Addus HomeCare Corporation (NASDAQ:ADUS) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 7,959 shares of the company’s stock, valued at approximately $799,000.

A number of other large investors also recently modified their holdings of the company. Leeward Investments LLC MA lifted its stake in Addus HomeCare by 9.4% in the 1st quarter. Leeward Investments LLC MA now owns 120,857 shares of the company’s stock worth $11,318,000 after purchasing an additional 10,414 shares in the last quarter. Summit Creek Advisors LLC purchased a new position in shares of Addus HomeCare during the 2nd quarter valued at $8,552,000. Bank of America Corp DE increased its holdings in shares of Addus HomeCare by 11.3% in the first quarter. Bank of America Corp DE now owns 323,037 shares of the company’s stock worth $30,252,000 after purchasing an additional 32,714 shares during the period. Vanguard Group Inc. raised its position in shares of Addus HomeCare by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 1,308,605 shares of the company’s stock worth $140,531,000 after buying an additional 10,501 shares in the last quarter. Finally, TimesSquare Capital Management LLC purchased a new stake in shares of Addus HomeCare in the second quarter worth $31,502,000. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Price Performance

NASDAQ ADUS opened at $118.76 on Monday. Addus HomeCare Corporation has a 1 year low of $87.95 and a 1 year high of $124.43. The stock has a market capitalization of $2.22 billion, a PE ratio of 20.84, a PEG ratio of 1.59 and a beta of 0.86. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.69 and a quick ratio of 1.69. The business’s 50-day moving average is $114.01 and its 200 day moving average is $103.13.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, August 3rd. The company reported $1.73 EPS for the quarter, beating analysts’ consensus estimates of $1.70 by $0.03. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%.The business had revenue of $377.41 million during the quarter, compared to analyst estimates of $376.24 million. During the same quarter in the prior year, the company posted $1.49 EPS. Addus HomeCare’s quarterly revenue was up 8.0% compared to the same quarter last year. Sell-side analysts forecast that Addus HomeCare Corporation will post 6.3 earnings per share for the current year.

Insider Activity

In related news, insider Heather Dixon sold 288 shares of the company’s stock in a transaction that occurred on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total transaction of $27,005.76. Following the completion of the transaction, the insider owned 44,371 shares in the company, valued at $4,160,668.67. This represents a 0.64% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 4.10% of the company’s stock.

Analyst Ratings Changes

ADUS has been the subject of several research analyst reports. Citigroup reissued a “market outperform” rating on shares of Addus HomeCare in a research note on Friday, July 24th. Barclays lifted their price target on Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a research report on Wednesday, July 8th. Weiss Ratings upgraded Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 9th. Royal Bank Of Canada boosted their price objective on shares of Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. Finally, Citizens Jmp reiterated a “market outperform” rating and issued a $142.00 price objective on shares of Addus HomeCare in a report on Monday, May 18th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Addus HomeCare has a consensus rating of “Moderate Buy” and an average price target of $128.86.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.